Clinical trial · Interventional
Electrochemotherapy for the Inoperable Vulva Carcinoma
Prospective Evaluation of Clinical Efficacy and Symptom Control Using Electrochemotherapy for the Inoperable Advanced Vulva Carcinoma
NCT03142061CI-TRIAL-00079017completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Electrochemotherapy (ECT) with Bleomycin in non-operable advanced vulva carcinoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Inoperable Vulva Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Electrochemotherapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ECT
- interventionNames
- Procedure: Electrochemotherapy
Primary outcomes (2)
- measure
- local tumor control
- timeFrame
- Baseline
- description
- according to RECIST criteria
- measure
- Symptom control
- timeFrame
- Baseline
- description
- exulceration, secretion
Secondary outcomes (2)
- measure
- Life quality
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * informed consent * age ≥ 55 years (postmenopausal) * histologically proved cutan accessible vulva carcinoma * a maximum of 5 lesions ≥1 - ≤ 5 cm diameter; a maximum thickness of 3 cm * applied electrochemotherapy with electroporation Exclusion Criteria: * Non compliant patients * Patients with symptomatic or rapidly progredient metastasis outside of the vulva
References
Publications (0)
Data not yet available
No reference posted for this study.